Damiana Leaf - NutraPedia

Back to Table of Contents

Research Overview

Overall, research on damiana (Turnera diffusa) is dominated by phytochemical characterization and preclinical bioactivity testing. Reviews of the genus Turnera document a diverse secondary-metabolite profile—particularly flavonoids (e.g., apigenin; damiana also contains other flavonoids reported in the literature such as pinocembrin and acacetin), along with phenolics, terpenoids, cyanogenic glycosides, and other constituents—and map these to a wide range of proposed activities (antioxidant, antidiabetic, antimicrobial, gastroprotective/hepatoprotective, antispasmodic, anxiolytic, cytotoxic, and aphrodisiac). However, for most indications the evidence base remains largely chemical, cell-based, or animal-model driven, and only a few traditional uses have been linked to specific compounds with mechanistic support (e.g., apigenin identified as an antinociceptive principle in animal experiments).

The strongest evidence in the studies reviewed here supports (i) short-term appetite/energy-intake reduction in humans for a multi-ingredient formulation containing yerba maté, guarana, and damiana (double-blind, placebo-controlled, cross-over study), and (ii) antioxidant/anti-inflammatory–linked protective effects in animal and mechanistic models relevant to damiana constituents. In rats, Turnera diffusa administration improved biochemical, hormonal, and histological markers in a model of pesticide/heavy-metal–induced testicular oxidative injury, consistent with an antioxidant protective role. Separately, pinocembrin—described as a predominant flavonoid found in damiana among other sources—suppressed osteoclastogenesis and bone resorption in ovariectomized mice and in cell assays via inhibition of RANKL-driven NF-κB/NFATc1 signaling and reduction of ROS, supporting a plausible mechanism for anti-resorptive effects, though not yet specific to damiana extracts as a clinical intervention.

Key gaps are the limited number of rigorous human trials of damiana as a single-agent intervention, uncertainty about which constituents drive specific clinical effects, and incomplete safety/toxicology and pharmacokinetic profiling. The appetite study used a combination product, making damiana’s independent contribution difficult to isolate, and many other claimed activities (including aphrodisiac and women’s health indications) remain under-tested in well-controlled clinical designs. Future research priorities include standardized extract characterization, dose–response studies, identification of active principles and biomarkers of exposure/effect, evaluation of drug–herb interactions, and well-powered randomized controlled trials targeting the most plausible indications suggested by preclinical mechanisms (e.g., oxidative-stress modulation, inflammation-related endpoints, and potentially bone-resorption pathways).

1. What conditions has Damiana been studied for?

  • Toxicant-induced male reproductive/testicular injury (animal model): Turnera diffusa (damiana) was studied in rats for protection against fenitrothion (pesticide) and/or potassium dichromate (CrVI)-induced testicular toxicity and oxidative injury.

  • Appetite/food intake (human study, multi-ingredient product): Damiana as part of a patented combination (Yerbe Maté + Guarana + Damiana; “YGD”), alone or with an inulin-based soluble fermentable fiber, was studied for short-term effects on appetite and caloric intake in normal to slightly overweight women.

  • Sexual function/aphrodisiac use (traditional + limited human evidence in combinations): A Turnera genus review notes damiana is a highly appreciated traditional aphrodisiac; human assessments of female sexual function were reported but used multi-ingredient products containing damiana.

  • Menopausal symptoms (human RCT, multi-ingredient product): Damiana was included in “Lady 4” (evening primrose oil, damiana, ginseng, royal jelly) studied for menopausal syndrome using the Menopause Rating Scale II.

  • Antioxidant/antibacterial activity (in vitro): Damiana was evaluated in vitro for antioxidant and antibacterial activity against Staphylococcus aureus and Streptococcus pyogenes (HPTLC-direct bioautography).

  • Immune parameters/infection response (animal/aquaculture model): Damiana-enriched diets (0.5%) were studied in Almaco Jack fish for mucus/serum immune parameters and intestinal gene expression, including after infection with Aeromonas hydrophila (abstract truncated but indicates this direction).

  • Bone resorption/osteolysis (compound found in damiana; animal + cell studies): Pinocembrin, described as a predominant flavonoid found in damiana (also in honey/fingerroot/propolis), was studied in ovariectomized mice and osteoclast cell models for anti-resorptive effects.

  • Inflammation/cancer and other disease areas (compound found in damiana; review-level evidence): Acacetin (present in damiana among other plants) is reviewed for anti-inflammatory, anticancer, cardioprotective, neuroinflammation, lung injury, anti-obesity, antimicrobial, antiviral, and hepatoprotective effects—mostly preclinical.

2. Does it work in treating those conditions? Summarize the evidence.

  • Testicular toxicity/oxidative injury (rats): In pesticide (FNT) and/or CrVI-intoxicated rats, damiana pretreatment significantly improved oxidative stress markers (e.g., reduced lipid peroxidation; improved antioxidant enzymes), and improved reproductive hormones (testosterone and FSH) versus intoxicated controls. Histological/immunohistochemical testicular alterations were also improved. This supports a protective effect in an animal toxicology model, but it does not establish clinical efficacy in humans.

  • Appetite and short-term caloric intake (humans; YGD combination): In a double-blind, placebo-controlled, cross-over study (58 women), the YGD formulation produced significant short-term reductions in food and energy intake at an ad libitum lunch (reported reductions ~16–17% when YGD was present). Effects were augmented when combined with soluble fermentable fiber. However, because damiana was part of a multi-ingredient product (with yerba maté and guarana), the study does not isolate damiana’s independent effect.

  • Menopausal symptoms (humans; Lady 4 combination): In a randomized placebo-controlled trial (120 women), the combination product containing damiana improved Menopause Rating Scale II scores more than placebo (p < 0.001). This suggests the combination may help menopausal symptoms, but the study does not allow attribution specifically to damiana.

  • Sexual function/aphrodisiac claims: The Turnera review notes traditional aphrodisiac use and that female sexual function has been assessed in humans using products that included damiana plus other ingredients. The evidence in the studies reviewed here is therefore suggestive but not definitive for damiana alone.

  • Antibacterial/antioxidant activity (in vitro): Damiana showed antioxidant and antibacterial activity against S. aureus and S. pyogenes in an HPTLC-direct bioautography screening. This is preclinical and does not prove clinical treatment of infections.

  • Bone resorption (pinocembrin; mice + cells): Pinocembrin inhibited osteoclastogenesis and bone resorption in ovariectomized mice and in RANKL-stimulated cell models, via suppression of NF-κB/NFATc1 signaling and reduction of ROS. This supports a mechanistic and animal-model anti-resorptive effect, but it is evidence for a compound found in damiana, not necessarily for typical damiana supplements or doses.

  • Broad anti-inflammatory/anticancer potential (acacetin; review): The acacetin review describes multiple pharmacological activities largely from cell/animal studies and explicitly concludes that further scientific evidence is essential and that toxicity profiling is limited. This is hypothesis-generating rather than proof of clinical efficacy.

3. What health benefits does it have?

  • Antioxidant and tissue-protective effects (preclinical): In rats exposed to FNT/CrVI, damiana improved oxidative stress parameters and supported recovery of testicular hormones and tissue markers, consistent with an antioxidant/protective profile in that model.

  • Potential appetite/calorie intake reduction (human evidence, but not damiana-only): A damiana-containing YGD product reduced short-term food and energy intake in a controlled human study; the effect was stronger with added fermentable fiber.

  • Possible menopausal symptom relief (human evidence, combination product): A damiana-containing combination (Lady 4) improved menopausal symptom scores more than placebo over 2–4 weeks.

  • Antibacterial activity (in vitro): Screening showed activity against S. aureus and S. pyogenes, which may justify further study but is not clinical proof.

  • Mechanistic potential relevant to bone health (compound-level evidence): Pinocembrin (reported as present in damiana) reduced osteoclast formation and bone resorption in ovariectomy-related bone loss models, suggesting a plausible pathway for anti-resorptive benefits—pending human validation.

  • Other proposed benefits (mostly preclinical/ethnobotanical): The Turnera review lists experimentally observed activities across extracts/compounds (e.g., antianxiety, antidiabetic, gastroprotective, hepatoprotective, antispasmodic, aphrodisiac), but emphasizes that most evidence is chemical/cell/animal and often not linked to specific compounds (exception noted: apigenin as an antinociceptive principle in animal experiments).

4. Does it have any downsides or side effects?

  • Limited direct safety data for damiana alone in these studies: The provided damiana rat study focuses on protective effects and does not describe clear adverse outcomes from damiana alone in that context, but animal findings do not guarantee human safety.

  • Product contamination/adulteration risk (commercial “herbal” vaping/extract products): An analytical study of commercially sold “herb” powders/resins/e-liquids found psychoactive and potentially harmful substances in some products (e.g., arecoline/arecaidine, mitragynine/7-hydroxymitragynine, nuciferine, coumarin). Damiana was among the purchased “herbs,” and the study highlights that some marketed natural products may contain unexpected psychoactives. This is a quality/safety risk rather than a proven intrinsic toxicity of damiana.

  • Acacetin toxicity uncertainty: The acacetin review (acacetin is present in damiana) explicitly notes limited information available for toxicity profiling and calls for further studies. This implies uncertainty around safety at pharmacologic exposures.

  • Attribution problem in combination trials: Human trials cited used multi-ingredient products (YGD; Lady 4). Side effects attributable specifically to damiana cannot be determined from these studies alone.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

The studies reviewed here do not report pharmacogenomic analyses (e.g., effects by CYP450 genotype, transporter variants, receptor polymorphisms) for damiana, Turnera extracts, or damiana-derived compounds.

  • No direct evidence: None of the included damiana-related studies stratified outcomes or adverse effects by genetic variants.

  • Indirect mechanistic hints are not pharmacogenomics: The pinocembrin study implicates NF-κB/NFATc1 signaling and oxidative stress pathways in osteoclasts, and the acacetin review discusses broad mechanisms, but neither provides genotype-specific benefit/harm data.

Damiana Leaf (Turnera diffusa) Research Summary

General Information

Damiana, scientifically known as Turnera diffusa, is a plant traditionally used for medicinal purposes including as an aphrodisiac and for enhancing sexual function.

Research Highlights

  • A study developed a method using high-performance thin-layer chromatography (HPTLC) to measure levels of apigenin, an anxiolytic compound, in Turnera aphrodisiaca. The highest content was found in flowers, followed by leaves.
  • Another study found that a methanolic extract from damiana leaves inhibited the aromatase enzyme and displayed estrogenic activity. The compounds pinocembrin and acacetin were particularly effective in aromatase inhibition.
  • The essential oils of wild damiana plants differ in composition from those grown through micropropagation techniques, with the latter showing more consistent quality and quantity.
  • Phytochemical analysis of Turnera diffusa identified 35 different chemical compounds including flavonoids, terpenoids, and phenolics. Six compounds were newly discovered.
  • The compound Tetraphyllin B was isolated from damiana and characterized using NMR spectroscopy and Mass Spectrometry (MS).
  • Research on sexually exhausted male rats showed that damiana could help in recovering from sexual inhibition. Caffeine, arbutine, and flavonoids were identified as main components of the active extract.
  • A study established pharmacognostic standards for T. aphrodisiaca, finding unique microscopic characteristics and bioactive compounds for quality control.
  • Turnera diffusa and Pfaffia paniculata extracts improved the sexual performance of sexually sluggish or impotent male rats.
  • Methanol extract of Turnera aphrodisiaca had significant anti-anxiety effects in mice.
  • Apigenin from T. aphrodisiaca showed anxiolytic and mild sedative effects, as well as a dose-dependent analgesic effect in tests.
  • A South American herbal preparation 'YGD', containing Damiana, delayed gastric emptying and induced weight loss in overweight patients.
  • Arbutin from damiana showed anti-ulcer activity by inhibiting lipid peroxidation and modulating cytokine levels.
  • Extracts from Turnera diffusa demonstrated hepatoprotective properties against CCl₄-induced liver damage.
  • Plant extracts, including those from damiana, were found to relax smooth muscle in the corpus cavernosum of guinea pigs, suggesting vasodilatory potential.

Conclusion

Overall, the research supports traditional uses of damiana leaf for treating sexual dysfunction, anxiety, and other health conditions. The various studies highlight its potential pharmacological benefits, including anti-aromatase, estrogenic, anxiolytic, and hepatoprotective effects, as well as its use in weight management and ulcer treatment.

References:


  1. Damiana
  2. Estimation of Apigenin, an Anxiolytic Constituent, in Turnera aphrodisiaca
  3. Anti-aromatase activity of the constituents from damiana (Turnera diffusa)
  4. Analysis of essential oils from wild and micropropagated plants of damiana (Turnera diffusa)
  5. Phytochemical investigation of Turnera diffusa
  6. Tetraphyllin B from Turnera diffusa
  7. Turnera diffusa Wild (Turneraceae) recovers sexual behavior in sexually exhausted males
  8. Mexican medicinal plants. XXVIII. Isolation of 5-hydroxy-7,3',4'-trimethoxy-flavone from Turnera diffusa
  9. Pharmacognostic standardization of Turnera aphrodisiaca Ward
  10. Stimulating property of Turnera diffusa and Pfaffia paniculata extracts on the sexual-behavior of male rats
  11. Anti-anxiety activity studies of various extracts of Turnera aphrodisiaca Ward
  12. Pharmacological evaluation of Bioactive Principle of Turnera aphrodisiaca
  13. Hypoglycemic herbs and their action mechanisms
  14. Weight loss and delayed gastric emptying following a South American herbal preparation in overweight patients
  15. Gastroprotective activities of Turnera diffusa Willd. ex Schult. revisited: Role of arbutin
  16. Protective effect of four Mexican plants against CCl₄-induced damage on the Huh7 human hepatoma cell line
  17. Argentinian plant extracts with relaxant effect on the smooth muscle of the corpus cavernosum of guinea pig
  18. Acacetin, a flavone with diverse therapeutic potential in cancer, inflammation, infections and other metabolic disorders.
    Shilpi Singh, Pratima Gupta, Abha Meena, Suaib Luqman (2020) - Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
  19. Modulatory effect of Turnera diffusa against testicular toxicity induced by fenitrothion and/or hexavalent chromium in rats.
    Fatma M El-Demerdash, Ali B Jebur, Hoda M Nasr, Hanin M Hamid (2019) - Environmental toxicology
  20. Ethnobotany, phytochemistry, and bioactivity of the genus Turnera (Passifloraceae) with a focus on damiana--Turnera diffusa.
    Katarzyna Szewczyk, Christian Zidorn (2014) - Journal of ethnopharmacology
  21. Therapeutic potential of a prominent dihydroxyflavanone pinocembrin for osteolytic bone disease:
    Guoju Hong, Shuqiang Li, Guanqiang Zheng, Xiaoxia Zheng, Qunzhang Zhan, Lin Zhou, Qiushi Wei, Wei He, Zhenqiu Chen (2024) - Journal of orthopaedic translation
  22. Acute effects of a herb extract formulation and inulin fibre on appetite, energy intake and food choice.
    J A Harrold, G M Hughes, K O'Shiel, E Quinn, E J Boyland, N J Williams, J C G Halford (2013) - Appetite
  23. Antidepressant-like and toxicological effects of a standardized aqueous extract of Chrysactinia mexicana A. Gray (Asteraceae) in mice.
    Julia Cassani, Octavio Alberto Ferreyra-Cruz, Ana María Dorantes-Barrón, Rosa María Vigueras Villaseñor, Daniel Arrieta-Baez, Rosa Estrada-Reyes (2015) - Journal of ethnopharmacology
  24. Antiphotoaging Effects of Damiana (
    Minseon Kim, Lee-Keun Ha, Sarang Oh, Minzhe Fang, Shengdao Zheng, Arce D Bellere, Jeehaeng Jeong, Tae-Hoo Yi (2022) - Plants (Basel, Switzerland)
  25. Acute Hypoglycemic and Antidiabetic Effect of Teuhetenone A Isolated from Turnera diffusa.
    Aída Parra-Naranjo, Cecilia Delgado-Montemayor, Alejandra Fraga-López, Gabriela Castañeda-Corral, Ricardo Salazar-Aranda, Juan José Acevedo-Fernández, Noemi Waksman (2017) - Molecules (Basel, Switzerland)
  26. In vivo and ex vivo studies support the immunostimulant and immunoprotective effect of Damiana (Turnera diffusa Willd) in Almaco Jack (Seriola rivoliana).
    Martha Reyes-Becerril, Minerva Maldonado, Sornkanok Vimolmangkang, Carlos Angulo (2024) - Fish & shellfish immunology
  27. The analysis of commercially available natural products recommended for use in electronic cigarettes.
    Michelle R Peace, Mika E Smith, Justin L Poklis (2020) - Rapid communications in mass spectrometry : RCM
  28. Effectiveness of a herbal formula in women with menopausal syndrome.
    Mostafa Yakoot, Amel Salem, Abdel-Mohsen Omar (2011) - Forschende Komplementarmedizin (2006)
  29. Quantitation of Synthetic Cannabinoids in Plant Materials Using High Performance Liquid Chromatography with UV Detection (Validated Method).
    Laura A Ciolino (2015) - Journal of forensic sciences
  30. Cytotoxic activity of the methanolic extract of Turnera diffusa Willd on breast cancer cells.
    María Del Carmen Avelino-Flores, María del Carmen Cruz-López, Fabiola E Jiménez-Montejo, Julio Reyes-Leyva (2015) - Journal of medicinal food
  31. Antioxidant responses of damiana (Turnera diffusa Willd) to exposure to artificial ultraviolet (UV) radiation in an in vitro model; part ii; UV-B radiation.
    Lluvia de Abril Alexandra Soriano-Melgar, Lilia Alcaraz-Meléndez, Lía C Méndez-Rodríguez, María Esther Puente, Fernando Rivera-Cabrera, Tania Zenteno-Savín (2014) - Nutricion hospitalaria
  32. Bioactivity of the GenusTurnera: A Review of the Last 10 Years
    Aída Parra-Naranjo, Cecilia Delgado-Montemayor, Ricardo Salazar-Aranda, Noemí Waksman-Minsky (2023)
  33. Mechanism of acacetin regulating hepatic stellate cell apoptosis based on network pharmacology and experimental verification.
    Xue Hu, Haotian Shen, Rong Liu, Bin Tang, Fengmei Deng (2024) - Heliyon
  34. Phyto-progestins for the treatment of abnormal uterine bleeding without organic cause in women at high risk for breast cancer and breast cancer survivors: a prospective, pilot study.
    Giovanni Grandi, Fabio Facchinetti, Chiara Melotti, Alice Sgandurra (2023) - Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
  35. Assessment of chemical, biological and immunological properties of "Damiana de California" Turnera diffusa Willd extracts in Longfin yellowtail (Seriola rivoliana) leukocytes.
    Martha Reyes-Becerril, Perla Ginera, Jorge Silva-Jara, Adriana Macias, Carlos Velazquez-Carriles, Lilia Alcaraz-Meléndez, Carlos Angulo (2020) - Fish & shellfish immunology
  36. Hepatodamianol as hepatoprotective constituent of Turnera diffusa.
    Cecilia Delgado-Montemayor, Jonathan Perez-Meseguer, Ricardo Salazar-Aranda, Paula Cordero-Perez, Noemí Waksman (2023) - Pakistan journal of pharmaceutical sciences
  37. Prosexual Effect ofChrysactinia mexicanaA. Gray (Asteraceae), False Damiana, in a Model of Male Sexual Behavior
    R Estrada-Reyes, O A Ferreyra-Cruz, G Jiménez-Rubio, O T Hernández-Hernández, L Martínez-Mota (2016)


Upload Whole Genome Sequencing (WGS) raw DNA data today and take a deep dive into your genome!

This article summarizes published research for educational purposes. It is not medical advice. Talk to your doctor before starting, stopping, or changing any supplement or medication.

Or if you only have standard microarray data currently, upload raw DNA data to get started with your free DNA raw data analysis today!